About Green Griffith
Green, Griffith & Borg-Breen LLP is a preeminent boutique intellectual property law firm, focusing on pharmaceuticals, chemistry and biotechnology—specializing in litigation. Our attorneys share decades of experience partnering with both brand and generic companies to navigate the most complex IP and related FDA issues, including the Hatch-Waxman Act.
IP Litigation Specialists
Acknowledged leaders in our field, we help clients build and execute targeted, timely and cost-effective IP strategies from project initiation through litigation, with an eye toward securing market position and overcoming obstacles to new product entry. Our range of services includes counseling regarding strategic formulation, portfolio and due diligence, as well as handling all stages of trial and appeals concerning IP and related FDA issues affecting 505(b)(1), 505(b)(2) and ANDA applications, as well as the BPCIA and biologics, and their related drug products and therapies.
Each of our attorneys have extensive scientific backgrounds—many with Ph.D.s—that permit exploration of technical solutions at a deep level. Our litigators have represented clients in matters pending throughout the United States, including all district courts known for handling major patent cases, as well as numerous other district courts, the PTAB, the Federal Circuit, the D.C. Court of Appeals and the United States Supreme Court. As a result, Green Griffith attorneys have deep and broad expertise in all phases of patent litigation from pre-litigation counseling through Markman hearings, dispositive motions, jury trials and appeals, as well as Inter Partes Reviews. This expertise positions us to work with each client to craft and execute the best strategy to attain our clients’ goals.
Our extensive experience, technical expertise, big picture vision and integrated strategy consistently produce favorable outcomes for companies developing, protecting and commercializing their products, processes and therapies.
Specialties: Patent Litigation including Hatch-Waxman Litigation, Chemical Patent Litigation and Pharmaceutical Patent Litigation, Client Counseling, IPR/PGR, Opinions, Acquisitions and Due Diligence.
- Ranked by IAM Patent 1000 for Litigation in Illinois (2017-2019)
- Nationally ranked by Managing IP for Life Sciences (2018-2019)
- Ranked as Recommended in Illinois by Managing IP for Patent Contentious (2018-2019)
- Nationally and regionally ranked in Litigation - Intellectual Property by U.S. News - Best Lawyers "Best Law Firms" (2018-2020)
- Regionally ranked in Patent Law by U.S. News - Best Lawyers "Best Law Firms" (2018-2020)
- Horizon Pharma
- Dexcel Ltd.
- Opiant Pharmaceuticals
- Clarus Therapeutics, Inc.
- Hikma Pharmaceuticals
- Aurobindo Pharma Ltd.
- Cipla Limited
- QuVa Pharma, Inc.
- Pharmgate Biologics Inc.
- Avadel Pharmaceuticals
- Hyloris Developments SA
- Milla Pharmaceuticals, Inc.
- RTU Pharma SA
About Our Clients
Green Griffith’s clients are pharma and biotech companies focused on securing market position and/or overcoming obstacles to new product entry for their drugs and therapies.
Our Clients Are Our Priority
We represent local, national and international pharmaceutical and biotech companies, and we tailor our approach to each client's specific needs and goals.
Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist pharmaceutical and biotech companies protect their most valuable assets and position them for future success. Our extensive experience, technical expertise, big picture vision and integrated strategy consistently produce favorable results for companies developing, protecting, and commercializing drugs and therapies. Our attorneys share decades of experience in partnering with both generic and brand companies, assisting them in navigating the most complex IP issues, including the Hatch-Waxman Act.
We represent local, national and international companies, from small startups to multinational businesses, and we tailor our approach to suit each client’s individual business needs and goals. We offer a full-service practice, helping clients acquire, manage, protect and enforce their intellectual property.
We focus on helping clients build effective IP strategies that secure market position or overcome obstacles to new product entry--whether this requires litigation or pre-litigation planning (505(b)(2), ANDA), Inter Partes Reviews, assessment of FDA exclusivity issues, opinions or portfolio analysis/development. Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.
We are committed to our clients and do what it takes to ensure their success. We are collaborative, proactive and strategic. We work as an extension of our client's team, making sure their needs are met. We partner with them to gain an understanding of their strategy, and then we help them refine and execute it. We value the trust and confidence our clients place in us. In return, we promise honesty, hard work and quality service.
Firm Practice Areas
- Litigation - Intellectual Property
- Litigation - Patent
- Patent Law
- Trade Secrets Law